Average Co-Inventor Count = 4.54
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Theravance Biopharma R&d Ip, LLC (23 from 262 patents)
2. Theravance, Inc. (14 from 386 patents)
3. Corvus Pharmaceuticals, Inc. (3 from 15 patents)
4. Angel Pharmaceutical Co., Ltd. (1 from 1 patent)
5. Corvus Biopharmaceuticals, Ltd. (0 patent)
41 patents:
1. 12358931 - 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor
2. 12172994 - Pyrimidine compound as JAK kinase inhibitor
3. 11897874 - Compounds and methods for modulating Interleukin-2-inducible T-cell kinase
4. 11814377 - Pyrimidine compound as JAK kinase inhibitor
5. 11780852 - Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
6. 11608354 - Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease
7. 11420965 - Pyrimidine compound as JAK kinase inhibitor
8. 11306099 - Compounds and methods for modulating Bruton's Tyrosine Kinase
9. 11110095 - Pyrimidine compounds as JAK kinase inhibitors
10. 11008314 - Compounds and methods for modulating interleukin-2-inducible t-cell kinase
11. 10988470 - Pyrimidine compound as JAK kinase inhibitor
12. 10961267 - Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease
13. 10947254 - Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
14. 10870652 - Compounds and methods for modulating bruton's tyrosine kinase
15. 10774080 - Pyrimidine compound as JAK kinase inhibitor